|
|
||||||||


1 Defence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK
2 Swedish Defence Research Agency, SE-901 82 Umeå, Sweden
3 Department of Infection, Immunity and Inflammation, Maurice Shock Building, University of Leicester, PO Box 138, Leicester LE1 9HN, UK
4 Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
Correspondence
Timothy S. Milne
TSMILNE{at}dstl.gov.uk
Received 26 January 2007
Accepted 13 June 2007
FTT0025 mutant produced an increased reaction zone compared with the wild-type, suggesting that siderophore production was unaffected but that the bacteria may have a deficiency in their ability to re-sequester this iron-binding molecule. Furthermore, the
FTT0025 mutant was attenuated in a BALB/c mouse model of infection relative to wild-type F. tularensis subsp. novicida U112.
Abbreviations: CAS, chrome azurol S; LVS, live vaccine strain; MLD, median lethal dose; s.c., subcutaneous.
Present address: School of Biosciences, Geoffrey Pope Building, University of Exeter, Exeter EX4 4QD, UK.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |